HOUSE DOCKET, NO. 4001 FILED ON: 1/20/2023
HOUSE . . . . . . . . . . . . . . . No. 3630
|
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Marjorie C. Decker
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act relative to the Massachusetts maternal mortality and morbidity review committee.
_______________
PETITION OF:
Name: | District/Address: | Date Added: |
Marjorie C. Decker | 25th Middlesex | 1/11/2023 |
Lindsay N. Sabadosa | 1st Hampshire | 1/20/2023 |
Sean Garballey | 23rd Middlesex | 1/20/2023 |
Carol A. Doherty | 3rd Bristol | 1/31/2023 |
HOUSE DOCKET, NO. 4001 FILED ON: 1/20/2023
HOUSE . . . . . . . . . . . . . . . No. 3630
By Representative Decker of Cambridge, a petition (accompanied by bill, House, No. 3630) of Marjorie C. Decker and others relative to establishing a maternal mortality and morbidity review committee within the Department of Public Health. Public Health. |
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Third General Court
(2023-2024)
_______________
An Act relative to the Massachusetts maternal mortality and morbidity review committee.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
Chapter 111 of the General Laws, as appearing in the 2020 Official Edition, is hereby amended by striking out section 24A and inserting in place thereof the following section:
Section 24A. (a) As used in this section, the following words shall, unless the context clearly requires otherwise, have the following meanings:-
"Maternal mortality," death, occurring in Massachusetts, of an individual during pregnancy through up to 1 year after pregnancy, irrespective of the duration and site of the pregnancy, from any cause.
“Committee,” the maternal mortality and morbidity review committee within the Massachusetts department of public health.
“Department,” the department of public health.
“Commissioner,” the commissioner of public health.
(b) There is established a maternal mortality and morbidity review committee within the Massachusetts department of public health to review maternal deaths, study the incidence of pregnancy complications, make recommendations to improve maternal outcomes, and eliminate preventable maternal deaths. The committee shall:
(1) conduct case reviews of the pregnancy-related and pregnancy-associated maternal deaths of women in Massachusetts;
(2) improve the ability to provide high-quality, evidence-based health care to women and infants in Massachusetts;
(3) identify gaps in the provision of health care services including, but not limited to, quality of care, access to the most appropriate health care, transportation and lack of financial resources by analyzing:
(i) the race, ethnicity and age of mothers who experience maternal mortality;
(ii) the geographic region of the residence of mothers who experience maternal mortality; and
(iii) the socioeconomic status of mothers who experience maternal mortality
(4) review probable cause of death and identify contributing factors;
(5) determine whether the death was preventable, and if so what actions could have been taken to prevent the death;
(6) make recommendations for changes in law, policy, and practice that will prevent maternal mortality and eliminate long standing race-based inequalities; and
(7) request and obtain a copy of all records and reports pertaining to the pregnancy-related and pregnancy-associated maternal mortality or near-death case under review. All case reviews shall remain in the possession of committee staff and only de-identified information will be presented to the committee.
(c) The committee will maintain all confidential information, documents and records in possession of the committee as confidential and not subject to subpoena or discovery in any civil or criminal proceedings; provided however, information, documents and records otherwise available from other sources shall not be exempt from subpoena or discovery through those sources solely because such information, documents and records were presented to or reviewed by the committee.
A physician, hospital or pharmacy providing access to medical records under this section shall not be held liable for civil damages or be subject to any criminal or disciplinary action for good faith efforts in providing such records.
Information, records, reports, statements, notes, memoranda or other data collected under this section shall not be admissible as evidence in any action of any kind in any court or before any other tribunal, board, agency or person. Such information, records, reports, statements, notes, memoranda or other data shall not be exhibited nor their contents disclosed in any way, in whole or in part, by any officer or representative of the department or any other person, except as may be necessary for the purpose of furthering the review of the committee of the case to which they relate. No person participating in such review shall disclose, in any manner, the information so obtained except in strict conformity with such review project.
All proceedings and activities of the committee under this section, opinions of members of the committee formed as a result of those proceedings and activities, and records obtained, created, or maintained under this section, including records of interviews, written reports and statements procured by the department or any other person, agency or organization acting jointly or under contract with the department in connection with the requirements of this section, shall be confidential
Members of the committee shall not be questioned in any civil or criminal proceeding regarding the information presented in or opinions formed as a result of a meeting or communication of the committee; however, nothing in this section shall be construed to prevent a member of the committee from testifying to information obtained independently of the proceedings of the committee or which is public information.
(d) The commissioner or the commissioner's designee shall chair the committee. Each member shall serve for a term of 3 years and until their successor is appointed. Nothing shall prohibit the commissioner from appointing a committee member to serve additional terms. Committee members shall be compensated for their participation on the committee and be reimbursed for ordinary and necessary expenses for the performance of their duties (mileage and tolls). The department shall convene the committee on a regular basis as deemed necessary by the department. In appointing members of the committee, the commissioner shall include members that work in and represent communities that are most impacted per the state maternal mortality ratio so that the composition of the committee reflects:
(1) the racial, ethnic and linguistic diversity of the state;
(2) the differing geographic regions within the state, including rural and urban areas; and
(3) communities that are most impacted by pregnancy-related deaths, severe maternal morbidity and a lack of access to relevant perinatal and intrapartum care services.
The committee shall not exceed 25 members, who shall be appointed by the commissioner. The committee shall include
(1) A representative of the department of public health;
(2) A representative of the Massachusetts Perinatal Neonatal Quality Improvement Network;
(3) The Chief Medical Examiner or a designee;
(4) The chair of the Massachusetts chapter of the American College of Obstetrics and Gynecology or a designee;
(5) The chair of the Massachusetts chapter of the American College of Nurse Midwives or a designee;
(6) The chair of the Massachusetts chapter of the Association of Women's Health, Obstetric and Neonatal Nurses or a designee;
(7) A medical professional with obstetric and neonatal nursing training;
(8) A medical professional with training in cardiology;
(9) A medical professional with training in pathology;
(10) A medical professional with expertise in substance use prevention and treatment;
(11) A psychology, social work or other mental health professional;
(12) A representative from academia;
(13) A medical professional with formal anesthesiology training;
(14) A medical professional with maternal fetal medicine or perinatology training;
(15) A medical professional with psychiatric training;
(16) A medical professional with family medicine training;
(17) A director of a federally funded-Healthy Start program or a designee;
(18) A minimum of two doulas;
(19) A minimum of two community or family members who have been directly affected by a maternal death and another person, selected by majority vote of the members of the committee, with relevant expertise or knowledge;
(20) A member of a community-based organization;
(21) A representative from the department of children and families; and
(22) A law enforcement officer.
(e) On or before December 31 of each even-numbered year the committee will develop and submit to the Legislature and any other organization the committee determines as necessary to facilitate the objectives of the committee a report that includes, without limitation:
(1) A description of the incidents of maternal mortality and severe maternal morbidity reviewed during the immediately preceding 24 months, provided in a manner that does not allow for the identification of any person;
(2) A summary of the disparities identified and reviewed.
(3) Plans for corrective action to reduce maternal mortality and severe maternal morbidity in this State; and
(4) Recommendations for any legislation or other changes to policy to reduce maternal mortality and severe maternal morbidity or otherwise improve the delivery of health care in this Commonwealth.